# Publications and Patents
<B>Benjamin P. Fauber, Ph.D.</B>
<BR>
Peer-reviewed Publications, Issued Patents, and Invited Presentations
<BR>

<B>Peer-Reviewed Publications</B>

1. Zbieg, J. R.; <B>Fauber, B. P.</B>; Miller, S. L.; René, O. Addition of Potassium Organotrifluoroboronates to <I>N,S</I>-Sulfonyl Acetals to Provide 1-Substituted Tetrahydro-<I>β</I>-carbolines. <I>Manuscript in preparation.</I>

2.	Purkey, H. E.; Robarge, K.; Chen, J.; Chen, Z.; Corson, L. B.; Ding, C. Z.; DiPasquale, A. G.; Dragovich, P. S.; Eigenbrot, C.; Evangelista, M.; <B>Fauber, B. P.</B>; Gao, Z.; Ge, H.; Hitz, A.; Ho, Q.; Labadie, S. S.; Lai, K. W.; Liu, W.; Liu, Y.; Li, C.; Ma, S.; Malek, S.; O'Brien, T.; Pang, J.; Peterson, D.; Salphati, L.; Sideris, S.; Ultsch, M.; Wei, B.; Yen, I.; Yue, Q.; Zhang, H.; Zhou, A. Cell Active Hydroxylactam Inhibitors of Human Lactate Dehydrogenase With Oral Bioavailability in Mice. <I>ACS Med. Chem. Lett.</I> <B>2016</B>, <I>7</I>, 896-901. <A HREF="http://pubs.acs.org/doi/abs/10.1021/acsmedchemlett.6b00190">-link-</A>

3. René, O.; <B>Fauber, B. P.</B>; Barnard, A.; Chapman, K.; Deng, Y.; Eidenschenk, C.; Everett, C.; Gobbi, A.; Johnson, A. R.; La, H.; Norman, M.; Salmon, G.; Summerhill, S.; Wong, H. Discovery of Oxa-Sultams as RORc Inverse Agonists Showing Reduced Lipophilicity, Improved Selectivity, and Favorable ADME Properties. <I>Bioorg. Med. Chem. Lett.</I> <B>2016</B>, <I>26</I>, 4455-4461. <A HREF="http://www.sciencedirect.com/science/article/pii/S0960894X16308095">-link-</A>

4. René, O.; Stepek, I. A.; Gobbi, A.; <B>Fauber, B. P.</B>; Gaines, S. Palladium Catalyzed Ring Expansion of Spirocyclopropanes to Form Caprolactams and Azepanes. <I>J. Org. Chem.</I> <B>2015</B>, <I>80</I>, 10218-10225. <A HREF="http://pubs.acs.org/doi/abs/10.1021/acs.joc.5b01846">-link-</A>

5. <B>Fauber, B. P.</B>; Gobbi, A.; Savy, P.; Burton, B.; Deng, Y.; Everett, C.; La, H.; Johnson, A. R.; Lockey, P.; Norman, M.; Wong, H. Identification of <I>N</I>-Sulfonyl-tetrahydroquinolines as RORc Inverse Agonists. <I>Bioorg. Med. Chem. Lett.</I> <B>2015</B>, <I>25</I>, 4109-4113. <A HREF="http://www.sciencedirect.com/science/article/pii/S0960894X1500863X">-link-</A>

6. <B>Fauber, B. P.</B>; René, O.; Deng, Y.; DeVoss, J.; Eidenschenk, C.; Everett, C.; Ganguli, A.; Gobbi, A.; Hawkins, J.; Johnson, A. R.; La, H.; Lesch, J.; Lockey, P.; Norman, M.; Ouyang, W.; Summerhill, S.; Wong, H. Discovery of 1-{4-[3-Fluoro-4-((3<I>S</I>,6<I>R</I>)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C (RORc or RORγ) Inverse Agonist. <I>J. Med. Chem.</I> <B>2015</B>, <I>58</I>, 5308-5322. <A HREF="http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.5b00597">-link-</A>

7. <B>Fauber, B. P.</B>; Gobbi, A.; Robarge, K.; Zhou, A.; Barnard, A.; Cao, J.; Deng, Y.; Eidenschenk, C.; Everett, C.; Ganguli, A.; Hawkins, J.; Johnson, A. R.; La, H.; Norman, M.; Salmon, G.; Summerhill, S.; Ouyang, W.; Tang, W.; Wong, H. Discovery of Imidazo[1,5-<I>a</I>]pyridines and -Pyrimidines as Potent and Selective RORc Inverse Agonists. <I>Bioorg. Med. Chem. Lett.</I> <B>2015</B>, <I>25</I>, 2907-2912. <A HREF="http://www.sciencedirect.com/science/article/pii/S0960894X15005296#">-link-</A>

8. Rutz, S.; Kayagaki, N.; Phung, Q. T.; Eidenschenk, C.; Noubade, R.; Wang, X.; Lesch, J.; Lu, R.; Newton, K.; Huang, O. W.; Cochran, A. G.; Vasser, M.; <B>Fauber, B. P.</B>; DeVoss, J.; Webster, J.; Diehl, L.; Modrusan, Z.; Kirkpatrick, D. S.; Lill, J. R.; Ouyang, W.; Dixit, V. M. Deubiquitinase DUBA is a Post-translational Brake on Interleukin-17 Production in T Cells. <I>Nature</I> <B>2015</B>, <I>518</I>, 417-421. <A HREF="http://www.nature.com/nature/journal/vaop/ncurrent/full/nature13979.html">-link-</A>

9. René, O.; <B>Fauber, B. P.</B>; Boenig, G. D.; Burton, B.; Eidenschenk, C.; Everett, C.; Gobbi, A.; Hymowitz, S. G.; Johnson, A. R.; Kiefer, J. R.; Liimatta, M.; Lockey, P.; Norman, M.; Ouyang, W.; Wallweber, H. A.; Wong, H. A Minor Structural Change to Tertiary Sulfonamide RORc Ligands Led to Opposite Mechanisms of Action. <I>ACS Med. Chem. Lett.</I> <B>2015</B>, <I>6</I>, 276-281. <A HREF="http://pubs.acs.org/doi/abs/10.1021/ml500420y">-link-</A>

10. <B>Fauber, B. P.</B>; Clagg, K.; Gibbons, P.; René, O. Experimental and Computational Studies of the Diastereoselective Alkylations of 3-Substituted γ-Sultams. <I>J. Org. Chem.</I> <B>2015</B>, <I>80</I>, 685-689. <A HREF="http://pubs.acs.org/doi/abs/10.1021/jo502506j">-link-</A>

11. Labadie, S.; Dragovich, P. S.; Chen, J.; <B>Fauber, B. P.</B>; Boggs, J.; Corson, L. B.; Ding, C.; Eigenbrot, C.; Ge, H.; Ho, Q.; Lai, K. W.; Ma, S.; Malek, S.; Peterson, D.; Purkey, H. E.; Robarge, K.; Salphati, L.; Sideris, S.; Ultsch, M.; VanderPorten, E.; Wei, B.; Xu, Q.; Yen, I.; Yue, Q.; Zhang, H.; Zhang, X.; Zhou, A. Optimization of 3-Hydroxy-5-(2,6-dichlorophenyl)-2-mercaptocyclohex-2-enones as Potent Inhibitors of Human Lactate Dehydrogenase. <I>Bioorg. Med. Chem. Lett.</I> <B>2015</B>, <I>25</I>, 75-82. <A HREF="http://www.sciencedirect.com/science/article/pii/S0960894X14011792#">-link-</A>

12.	van Niel, M. B.; <B>Fauber, B. P.</B>; Cartwright, M.; Gaines, S.; Killen, J. C.; René, O.; Ward, S. I.; Boenig, G. D.; Deng, Y.; Eidenschenk, C.; Everett, C.; Gancia, E.; Ganguli, A.; Gobbi, A.; Hawkins, J.; Johnson, A. R.; Kiefer, J. R.; La, H.; Lockey, P.; Norman, M.; Ouyang, W.; Qin, A.; Wakes, N.; Waszkowycz, B.; Wong, H. A Reversed Sulfonamide Series of Selective RORc Inverse Agonists. <I>Bioorg. Med. Chem. Lett.</I> <B>2014</B>, <I>24</I>, 5769-5776. <A HREF="http://www.sciencedirect.com/science/article/pii/S0960894X1401097X">-link-</A>

13. <B>Fauber, B. P.</B>; Dragovich, P. S.; Chen, J.; Corson, L. B.; Ding, C. Z.; Eigenbrot, C.; Labadie, S.; Malek, S.; Peterson, D.; Purkey, H. E.; Robarge, K.; Sideris, S.; Ultsch, M.; Wei, B.; Yen, I.; Yue, Q.; Zhou, A. Identification of 3,6-Disubstituted Dihydropyrones as Inhibitors of Human Lactate Dehydrogenase. <I>Bioorg. Med. Chem. Lett.</I> <B>2014</B>, <I>24</I>, 5683-5687. <A HREF="http://dx.doi.org/10.1016/j.bmcl.2014.10.067">-link-</A>

14. <B>Fauber, B. P.</B>; René, O.; Boenig, G. D.; Burton, B.; Deng, Y.; Eidenschenk, C.; Everett, C.; Gobbi, A.; Hymowitz, S. G.; Johnson, A. R.; La, H.; Liimatta, M.; Lockey, P.; Norman, M.; Ouyang, W.; Wang, W.; Wong, H. Reduction in Lipophilicity Improved the Solubility, Plasma-Protein Binding, and Permeability of Tertiary Sulfonamide RORc Inverse Agonists. <I>Bioorg. Med. Chem. Lett.</I> <B>2014</B>, <I>24</I>, 3891-3897. <A HREF="http://www.sciencedirect.com/science/article/pii/S0960894X14006763">-link-</A>

15.	Dragovich, P. S.; <B>Fauber, B. P.</B>; Boggs, J.; Chen, J.; Corson, L. B.; Ding, C. Z.; Eigenbrot, C.; Ge, H.; Giannetti, A. M.; Hunsaker, T.; Labadie, S.; Li, C.; Liu, Y.; Liu, Y.; Ma, S.; Malek, S.; Peterson, D.; Pitts, K. E.; Purkey, H. E.; Robarge, K.; Salphati, L.; Sideris, S.; Ultsch, M.; VanderPorten, E.; Wang, J.; Wei, B.; Xu, Q.; Yen, I.; Yue, Q.; Zhang, H.; Zhang, X.; Zhou, A. Identification of Substituted 3-Hydroxy-2-mercaptocyclohex-2-enones as Potent Inhibitors of Human Lactate Dehydrogenase. <I>Bioorg. Med. Chem. Lett.</I> <B>2014</B>, <I>24</I>, 3764-3771. <A HREF="http://www.sciencedirect.com/science/article/pii/S0960894X14007069">-link-</A>

16. René, O.; <B>Fauber, B. P.</B>; Malhotra, S.; Yajima, H. Palladium Catalyzed α-Arylation of Sultams with Aryl and Heteroaryl Iodides. <I>Org. Lett.</I> <B>2014</B>, <I>16</I>, 3468-3471. <A HREF="http://pubs.acs.org/doi/pdf/10.1021/ol501389k">-link-</A>

17. <B>Fauber, B. P.</B>; René, O.; Burton, B.; Everett, C.; Gobbi, A.; Hawkins, J.; Johnson, A. R.; Liimatta, M.; Lockey, P.; Norman, M.; Wong, H. Identification of Tertiary Sulfonamides as RORc Inverse Agonists. <I>Bioorg. Med. Chem. Lett</I>. <B>2014</B>, <I>24</I>, 2182-2187. <A HREF="http://www.sciencedirect.com/science/article/pii/S0960894X14002546">-link-</A>

18.	<B>Fauber, B. P.</B>; Johnson, A. R.; Bowerman, S.; Burton, B.; Colebrook, A.; Flynn, A.; Harrold, G.; Huhn, S.; Jones, G.; Lockey, P.; Norman, M.; René, O.; Wong, H. Syntheses of [<SUP>3</SUP>H<SUB>2</SUB>]T0901317 and a Labeled Structural Isomer, and Characterization of the Dispersed Labeled Compounds via <SUP>19</SUP>F NMR. <I>J. Labelled Comp. Radiopharm.</I> <B>2014</B>, <I>57</I>, 57-60. <A HREF="http://onlinelibrary.wiley.com/doi/10.1002/jlcr.3138/abstract">-link-</A>

19. René, O.; <B>Fauber, B. P.</B> Syntheses of 4-, 5-, 6- and 7-Substituted Tryptamine Derivatives and the Use of a Bromine Atom as a Protecting Group. <I>Tetrahedron Lett.</I> <B>2014</B>, <I>55</I>, 830-833. <A HREF="http://www.sciencedirect.com/science/article/pii/S004040391302100X">-link-</A>

20. <B>Fauber, B. P.</B>; Boenig, G. D.; Burton, B.; Eidenschenk, C.; Everett, C.; Gobbi, A.; Hymowitz, S. G.; Johnson, A. R.; Liimatta, M.; Lockey, P.; Norman, M.; Ouyang, W.; René, O.; Wong, H. Structure-Based Design of Substituted Hexafluoroisopropanol-Arylsulfonamides as Modulators of RORc. <I>Bioorg. Med. Chem. Lett.</I> <B>2013</B>, <I>23</I>, 6604-6609. <A HREF="http://www.sciencedirect.com/science/article/pii/S0960894X13012602">-link-</A>

21. <B>Fauber, B. P.</B>; Dragovich, P. S.; Chen, J.; Corson, L. B.; Ding, C. Z.; Eigenbrot, C.; Giannetti, A. M.; Hunsaker, T.; Labadie, S.; Liu, Y.; Liu, Y.; Malek, S.; Peterson, D.; Pitts, K.; Sideris, S.; Ultsch, M.; VanderPorten, E.; Wang, J.; Wei, B.; Yen, I.; Yue, Q. Identification of 2-Amino-5-aryl-pyrazines as Inhibitors of Human Lactate Dehydrogenase. <I>Bioorg. Med. Chem. Lett.</I> <B>2013</B>, <I>23</I>, 5533-5539. <A HREF="http://www.sciencedirect.com/science/article/pii/S0960894X13010007">-link-</A>

22. Dragovich, P. S.; <B>Fauber, B. P.</B>; Corson, L. B.; Ding, C. Z.; Eigenbrot, C.; Ge, H.; Giannetti, A. M.; Hunsaker, T.; Labadie, S.; Liu, Y.; Malek, S.; Pan, B.; Peterson, D.; Pitts, K.; Purkey, H. E.; Sideris, S.; Ultsch; M.; VanderPorten, E.; Wei, B.; Xu, Q.; Yen, I.; Yue, Q.; Zhang, H.; Zhang, X. Identification of Substituted 2-Thio-6-oxo-1,6-dihydropyrimidines as Inhibitors of Human Lactate Dehydrogenase. <I>Bioorg. Med. Chem. Lett.</I> <B>2013</B>, <I>23</I>, 3186-3194. <A HREF="http://www.sciencedirect.com/science/article/pii/S0960894X13004708">-link-</A>

23. Vasbinder, M. M.; Aquila, B.; Augustin, M.; Chen, H.; Cheung, T.; Cook, D.; Drew, L.; <B>Fauber, B. P.</B>; Glossop, S.; Grondine, M.; Hennessy, E. J.; Johannes, J.; Lee, S.; Lyne, P. D.; Morti, M.; Omer, C.; Palakurthi, S.; Pontz, T.; Read, J.; Sha, L.; Shen, M.; Steinbacher, S.; Wang, H.; Wu, A.; Ye, M.  Discovery and Optimization of a Novel Series of Potent Mutant B-Raf<SUP>V600E</SUP> Selective Kinase Inhibitors. <I>J. Med. Chem.</I> <B>2013</B>, <I>56</I>, 1996-2015. <A HREF="http://pubs.acs.org/doi/abs/10.1021/jm301658d">-link-</A>

24. René, O.; Souverneva, A.; Magnuson, S. R.; <B>Fauber, B. P.</B> Efficient Syntheses of 2-Fluoroalkylbenzimidazoles and -benzothiazoles. <I>Tetrahedron Lett.</I> <B>2013</B>, <I>54</I>, 201-204. <A HREF="http://www.sciencedirect.com/science/article/pii/S0040403912016450">-link-</A>

25. Yang, B.; Hird, A. H.; Russell, D. J.; <B>Fauber, B. P.</B>; Dakin, L. A.; Zheng, X.; Su, Q.; Godin, R.; Brassil, P.; Devereaux, E.; Janetka, J. W. Discovery of Novel Hedgehog Antagonists from Cell-Based Screening: Isosteric Modification of p38 Bisamides as Potent Inhibitors of SMO. <I>Bioorg. Med. Chem. Lett.</I> <B>2012</B>, <I>22</I>, 4907-4911. <A HREF="http://www.sciencedirect.com/science/article/pii/S0960894X12005549">-link-</A>

26.	Maurer, T.; Garrenton, L. S.; Oh, A.; Pitts, K.; Skelton, N. J.; <B>Fauber, B. P.</B>; Pan, B.; Malek, S.; Stokoe, D.; Bowman, K. K.; Wu, J.; Giannetti, A. M.; Starovasnik, M. A.; Mellman, I.; Jackson, P. K.; Rudolph, J.; Wang, W.; Fang, G. Small Molecule Ligands Bind to a Distinct Pocket in Ras and Inhibit SOS-Mediated Nucleotide Exchange Activity. <I>Proc. Natl. Acad. Sci. USA</I> <B>2012</B>, <I>109</I>, 5299-5304. <A HREF="http://www.pnas.org/content/109/14/5299.full.pdf+html">-link-</A>

27. Magnus, P.; Sane, N.; <B>Fauber, B. P.</B>; Lynch, V. Concise Syntheses of (-)-Galanthamine and (±)-Codeine via Intramolecular Alkylation of a Phenol Derivative. <I>J. Am. Chem. Soc.</I> <B>2009</B>, <I>131</I>, 16045-16047. <A HREF="http://pubs.acs.org/doi/pdf/10.1021/ja9085534">-link-</A>

28. Newhouse, B. J.; Allen, S.; <B>Fauber, B.</B>; Anderson, A. S.; Eary, C. T.; Hansen, J. D.; Schiro, J.; Gaudino, J. J.; Laird, E.; Chantry, D.; Eberhardt, C.; Burgess L. E. Racemic and Chiral Lactams as Potent, Selective, and Functionally Active CCR4 Antagonists. <I>Bioorg. Med. Chem. Lett.</I> <B>2004</B>, <I>14</I>, 5537-5542. <A HREF="http://www.sciencedirect.com/science/article/pii/S0960894X04010960">-link-</A>

29. Allen, S.; Newhouse, B.; Anderson, A. S.; <B>Fauber, B.</B>; Allen, A.; Chantry, D.; Eberhardt, C.; Odingo, J.; Burgess, L. E. Discovery and SAR of Trisubstituted Thiazolidinones as CCR4 Antagonists. <I>Bioorg. Med. Chem. Lett.</I> <B>2004</B>, <I>14</I>, 1619-1624. <A HREF="http://www.sciencedirect.com/science/article/pii/S0960894X04001519">-link-</A>

30. Tsujioka, S.; Nolan, B. G.; Takase, H.; <B>Fauber, B. P.</B>; Strauss, S. H. Conductivities and Electrochemical Stabilities of Lithium Salts of Polyfluoroalkoxyaluminate Superweak Anions. <I>J. Electrochem. Soc.</I> <B>2004</B>, <I>151</I>, A1418-A1423. <A HREF="http://jes.ecsdl.org/content/151/9/A1418">-link-</A>

31.	Polyakov, O. P.; Nolan, B. G.; <B>Fauber, B. P.</B>; Miller, S. M.; Anderson, O. P.; Strauss, S. H. Weakly Coordinating Anions HA<SUB>2</SUB><SUP>–</SUP> Generated from Oxoanions A<SUP>–</SUP> and their Conjugate Acids. Coordinating Equilibria, Ionic Conductivities, and the Structures of {Cu<SUB>2</SUB>(H(CH<SUB>3</SUB>SO<SUB>3</SUB>)<SUB>2</SUB>)<SUB>4</SUB>}<SUB>n</SUB> and [Cu(CO)(H(CF<SUB>3</SUB>CO<SUB>2</SUB>)<SUB>2</SUB>)]<SUB>2</SUB>. <I>Inorg. Chem.</I> <B>2000</B>, <I>39</I>, 1735-1742. <A HREF="http://pubs.acs.org/doi/pdf/10.1021/ic991165f">-link-</A>
<BR>
<BR>

<B>Review Articles</B>										

1. <B>Fauber, B. P.</B>; Magnuson, S. R. Modulators of the Nuclear Receptor Retinoic Acid Receptor Related Orphan Receptor-γ (RORγ or RORc). <I>J. Med. Chem.</I> <B>2014</B>, <I>57</I>, 5871-5892. <A HREF="http://pubs.acs.org/doi/abs/10.1021/jm401901d">-link-</A>
<BR>
<BR>

<B>Issued U.S. Patents</B>

1. <B>Fauber, B. P.</B>; Gaines, S.; Killen, J.; René, O.; van Niel, M. B.; Ward, S. Benzyl Sulfonamide Derivatives as RORc Modulators. U.S. Patent 9,382,222, July 5, 2016.

2. <B>Fauber, B. P.</B>; René, O.; van Niel, M. B.; Ward, S. Benzyl Sulfonamide Derivatives as RORc Modulators. U.S. Patent 9,302,985, Apr 5, 2016.

3. <B>Fauber, B. P.</B>; René, O. Benzyl Sulfonamide Derivatives as RORc Modulators. U.S. Patent 9,216,988, Dec 22, 2015.

4. <B>Fauber, B. P.</B>; Gains, S.; Gobbi, A.; René, O.; van Niel, M. B.; Vesey, D.; Ward, S. Aryl Sultam Derivatives as RORc Modulators. U.S. Patent 9,115,101, Aug 25, 2015.

5. <B>Fauber, B. P.</B>; René, O.; van Niel, M. B.; Ward, S. Aryl Sulfamide and Sulfamate Derivatives as RORc Modulators. U.S. Patent 8,912,219, Dec 16, 2014. 

6. Magnus, P. D.; <B>Fauber, B. P.</B>; Sane, N. J. Efficient Synthesis of Galanthamine. U.S. Patent 8,450,365, May 28, 2013.

7. Magnus, P. D.; <B>Fauber, B. P.</B>; Sane, N. J. Cross-conjugated 2,5-Cyclohexadienone and Related Synthesis Methods. U.S. Patent 8,362,283, Jan 29, 2013.

8. Magnus, P. D.; <B>Fauber, B. P.</B>; Sane, N. J. Efficient Synthesis of Morphine and Codeine. U.S. Patent 8,293,927, Oct 23, 2012. 

9. Strauss, S. H.; <B>Fauber, B. P.</B>; Nolan, B. G. Weakly-Coordinating Anions Containing Polyfluoroalkoxide Ligands. U.S. Patent 6,392,076, May 21, 2002.
<BR>
<BR>

<B>Patent Applications</B>

1. Bronner, S. M.; Crawford, J. J.; Cridland, A.; <B>Fauber, B. P.</B>; Gancia, E.; Hurley, C.; Killen, J.; van Niel, M. B.; Ward, S. Pyridazine Derivatives as RORc Modulators. WO 2016/177760, Nov 10, 2016.

2. Cridland, A.; <B>Fauber, B. P.</B>; Hurley, C.; Killen, J.; van Niel, M. B.; Ward, S.; Winship, P. Pyridazine Derivatives as RORc Modulators. WO 2016/177710, Nov 10, 2016.

3. Cridland, A.; <B>Fauber, B. P.</B>; Hurley, C.; Killen, J.; van Niel, M. B.; Ward, S. Pyridazine Derivatives as RORc Modulators. WO 2016/177686, Nov 10, 2016.

4. <B>Fauber, B. P.</B>; Ladduwahetty, T.; René, O. Heteroarylalkylene Aryl Sultam Derivatives as RORc Modulators. WO 2016/096936, June 23, 2016.

5. <B>Fauber, B. P.</B>; Gaines, S.; Killen, J.; van Niel, M. B.; Ward, S. Benzene Sulfonamide Derivatives as RORc Modulators. WO 2015/177325, Nov 26, 2015.

6. Chen, J.; Ding, C.; Dragovich, P. S.; <B>Fauber, B. P.</B>; Gao, Z.; Labadie, S.; Lai, K. W.; Purkey, H.; Robarge, K.; Wei, B.; Zhou, A. Piperidine Dione Derivatives. WO 2015/140133, Sept 24, 2015.

7. <B>Fauber, B. P.</B>; Gancia, E.; Gaines, S.; Gobbi, A.; Ladduwahetty, T.; René, O.; van Niel, M. B.; Vesey, D.; Ward, S.; Winship, P. Aryl Sultam Derivatives as RORc Modulators. WO 2015/104356, July 16, 2015.

8. <B>Fauber, B. P.</B>; Gancia, E.; Gaines, S.; Gobbi, A.; Hurley, C.; Ladduwahetty, T.; René, O.; van Niel, M. B.; Vesey, D.; Ward, S.; Winship, P. Aryl Sultam Derivatives as RORc Modulators. WO 2015/104354, July 16, 2015.

9. <B>Fauber, B. P.</B>; Malhotra, S.; René, O.; Yajima, H. Heteroaryl Sultam Derivatives as RORc Modulators. WO 2015/104353, July 16, 2015.

10. Cridland, A.; <B>Fauber, B. P.</B>; Gobbi, A.; Hurley, C.; Hurst, D.; Killen, J.; Maxey, R.; van Niel, M. B.; Ward, S. 5,6,7,8 Tetrahydro-5,8-Methanocinnoline Derivatives as RORc Modulators for the Treatment of Autoimmune Diseases. WO 2015/067575, May 14, 2015.

11. Cridland, A.; <B>Fauber, B. P.</B>; Gobbi, A.; Hurley, C.; Hurst, D.; Killen, J.; Maxey, R.; van Niel, M. B.; Ward, S. Pyridazine Derivatives as RORc Modulators. US 2015/0126491, May 7, 2015.

12. Albrecht, B. K.; Audia, J. E.; Bellon, S.; Cochran, A.; Cote, A.; Crawford, T.; <B>Fauber, B.</B>; Ghosh, S.; Harmanage, J. C.; Hatzivassiliou, G.; Jayaram, H.; Kim, J.; Lora, J. M.; Magnuson, S.; Mellman, I.; Romero, F. A.; Taylor, A. M.; Tsui, V. Use of CBP/EP300 Bromodomain Inhibitors for Cancer Immunotherapy. WO 2015/054642, Apr 16, 2015.

13.	<B>Fauber, B. P.</B>; Gobbi, A. Keto-imidazopyridine Derivatives as RORc Modulators. WO 2015/036411, Mar 19, 2015.

14.	<B>Fauber, B. P.</B>; René, O. Aryl Sultam Derivatives as RORc Modulators. WO 2014/202741, Dec 24, 2014.

15.	Albrecht, B. K.; Cote, A.; Crawford, T.; <B>Fauber, B. P.</B>; Huang, H.-R.; Lora, J. M.; Magnuson, S.; Nasveschuk, C. G.; Salmeron, A.; Sims, R. J.; Taylor, A. M. Treating T<SUB>H</SUB>2-Mediated Diseases by Inhibition of Bromodomains. WO 2014/144721, Sept 18, 2014.

16.	<B>Fauber, B. P.</B>; René, O.; van Niel, M. B.; Ward, S. Aryl Sulfamide and Sulfamate Derivatives as RORc Modulators. WO 2014/140059, Sept 18, 2014.

17.	<B>Fauber, B. P.</B>; Gaines, S.; Killen, J.; René, O.; van Niel, M. B.; Ward, S. Benzyl Sulfonamide Derivatives as RORc Modulators. WO 2014/090712, June 19, 2014.

18.	<B>Fauber, B. P.</B>; René, O.; van Niel, M. B.; Ward, S. Benzyl Sulfonamide Derivatives as RORc Modulators. WO 2014/090710, June 19, 2014.

19.	<B>Fauber, B. P.</B>; René, O.; van Niel, M. B.; Ward, S. Benzyl Sulfonamide Derivatives as RORc Modulators. US 2014/0163110, June 12, 2014.

20.	<B>Fauber, B. P.</B>; Gaines, S.; Killen, J.; René, O.; van Niel, M. B.; Ward, S. Benzyl Sulfonamide Derivatives as RORc Modulators. US 2014/0163024, June 12, 2014.

21. <B>Fauber, B. P.</B>; Gaines, S.; Gobbi, A.; René, O.; van Niel, M. B.; Vesey, D.; Ward, S. Aryl Sultam Derivatives as RORc Modulators. WO 2014/009447, Jan 16, 2014.

22.	<B>Fauber, B. P.</B>; René, O. Preparation of Benzylsulfonamide Derivatives as RORc Modulators for Treatment of Arthritis. WO 2013/092941, June 27, 2013.

23.	<B>Fauber, B. P.</B>; René, O. Preparation of Benzylsulfonamide Derivatives as RORc Modulators for Treatment of Arthritis. WO 2013/092939, June 27, 2013.

24.	Dakin, L.; <B>Fauber, B.</B>; Hird, A.; Janetka, J.; Russell, D. J.; Su, Q.; Yang, B.; Zheng, X. Heterocyclic Amides Useful for the Treatment of Cancer and Psoriasis. US 2010/0311748, Dec 9, 2010.

25.	Magnus, P. D.; <B>Fauber, B. P.</B>; Sane, N. Synthesis of Morphine and Related Derivatives. WO 2010/132570, Nov 18, 2010.

26.	<B>Fauber, B.</B>; Hird, A.; Janetka, J.; Russell, D. J.; Yang, B. Phenyl Carboxamide Derivatives as Inhibitors and Effectors of the Hedgehog Pathway. WO 2009/030952, Mar 12, 2009.

27.	Dakin, L.; <B>Fauber, B.</B>; Hird, A.; Janetka, J.; Russell, D. J.; Su, Q.; Yang, B.; Zheng, X. Heterocyclic Amides Useful for the Treatment of Cancer and Psoriasis. WO 2009/027746, Mar 5, 2009.

28.	Strauss, S. H.; <B>Fauber, B. P.</B>; Nolan, B. G. Weakly-Coordinating Anions Containing Polyfluoroalkoxide Ligands. WO 2000/053611, Sept 14, 2000.
<BR>
<BR>

<B>Invited Presentations</B>								

1.	The Scripps Research Institute, La Jolla, CA (April 2015)

2.	CHI Drug Discovery Chemistry Conference, San Diego, CA (April 2015)

3.	University of Colorado at Boulder, Boulder, CO (March 2015)

4.	249th American Chemical Society National Meeting, Denver, CO (March
2015)

5.	Medicinal Chemistry & Computer-Aided Drug Design Conference,
Burlingame, CA (December 2014)

6.	248th American Chemical Society National Meeting, San Francisco, CA
(August 2014)

7.	Argenta Discovery Ltd, Harlow, United Kingdom (March 2014) 

8.	Informa Drug Discovery Innovations Conference, Berlin, Germany (March
2014)

9.	Fort Lewis College, Durango, CO (October 2010)

10.	100th American Association for Cancer Research Annual Meeting, Denver, CO (April 2009)
